Aesculus Hippocastanum L. on Fontan Circulation

• Status: Withdrawn
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Patients after the Fontan operation at a single institution will be randomized to receive a standardized extract of Aesculus hippocastanum L. (horse chestnut) or placebo for 4 months in a crossover clinical trial. The primary outcome will be the mesenteric artery resistance measured by Dopple sonography.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Casa Espirita Terra de Ismael
• Collaborator: Hospital das Clínicas de Ribeirão Preto

Criteria

Inclusion Criteria:

• Underwent Fontan surgery

Exclusion Criteria:

• Severe adverse reaction

• Personal or parental request